
    
      The purpose of this study is to determine the safety, local tolerability and pharmacokinetic
      parameters of TOL-463 intravaginal dosage forms in both healthy, nonpregnant females
      following single dose administration (Part 1), and in nonpregnant women with vaginitis
      following multi-dose administration (Part 2).
    
  